Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
SAB Biotherapeutics, Inc. | Director | Series A-2 Convertible Preferred Stock | 28.4K | $28.4M | $1,000.00 | Nov 24, 2023 | Direct |
SAB Biotherapeutics, Inc. | Director | Common Stock | 4.58M | $4.03M | $0.88 | Nov 24, 2023 | Direct |
SAB Biotherapeutics, Inc. | Director | Tranche C Warrants | 52.1K | Nov 10, 2023 | Direct | ||
SAB Biotherapeutics, Inc. | Director | Tranche B Warrants | 20.8K | Nov 10, 2023 | Direct | ||
Provention Bio, Inc. | 10%+ Owner | Common Stock | 0 | $24.32 | Apr 27, 2023 | Direct | |
SAB Biotherapeutics, Inc. | Director | Series A-1 Convertible Preferred Stock | 0 | $1,000.00 | Nov 24, 2023 | Direct | |
SAB Biotherapeutics, Inc. | Director | Tranche A Warrants | 0 | Nov 13, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
SABS | SAB Biotherapeutics, Inc. | Nov 24, 2023 | 3 | -$2.89M | 4 | Nov 28, 2023 | Director |
SABS | SAB Biotherapeutics, Inc. | Nov 10, 2023 | 1 | $13.3M | 4/A | Nov 15, 2023 | Director |
SABS | SAB Biotherapeutics, Inc. | Oct 23, 2023 | 2 | $16.3M | 4 | Oct 24, 2023 | Director |
SABS | SAB Biotherapeutics, Inc. | Oct 2, 2023 | 0 | $0 | 3 | Oct 10, 2023 | Director |
PRVB | Provention Bio, Inc. | Apr 27, 2023 | 1 | $0 | 4 | Apr 28, 2023 | 10%+ Owner |
PRVB | Provention Bio, Inc. | Apr 20, 2023 | 2 | $0 | 4 | Apr 24, 2023 | 10%+ Owner |
PRVB | Provention Bio, Inc. | Apr 14, 2023 | 3 | -$14 | 4 | Apr 18, 2023 | 10%+ Owner |
PRVB | Provention Bio, Inc. | Mar 31, 2023 | 2 | $0 | 4 | Apr 4, 2023 | 10%+ Owner |
PRVB | Provention Bio, Inc. | Jan 18, 2023 | 1 | -$28.2M | 4 | Jan 20, 2023 | 10%+ Owner |
PRVB | Provention Bio, Inc. | Jul 7, 2022 | 0 | $0 | 3 | Jul 11, 2022 | 10%+ Owner |